Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Sales | 236 | 641 | 600 | 0 | 0 |
| Gross Profit | 236 | 641 | 600 | N/A | N/A |
| Operating Expenses | 239,112 | 6,216 | 2,869 | 0 | 0 |
| Operating Income | -238,876 | -5,575 | -2,269 | N/A | N/A |
| Interest Expense | 0 | 471 | 463 | 0 | 0 |
| Other Income | 1,699 | -138 | 686 | 0 | 0 |
| Pre-tax Income | -237,177 | -6,184 | -2,046 | 0 | 0 |
| Income Tax | -301 | 1 | 1 | N/A | N/A |
| Net Income Continuous | -236,876 | -6,185 | -2,047 | N/A | N/A |
| Net Income | $-236,876 | $-6,185 | $-2,047 | $N/A | $N/A |
| EPS Basic Total Ops | -3.31 | -0.75 | -2.57 | N/A | N/A |
| EPS Basic Continuous Ops | -3.31 | -0.75 | -2.57 | N/A | N/A |
| EPS Diluted Total Ops | -3.31 | -0.75 | -2.57 | N/A | N/A |
| EPS Diluted Continuous Ops | -3.31 | -0.75 | -2.57 | N/A | N/A |
| EBITDA(a) | $-237,366 | $-5,102 | $-1,946 | $N/A | $N/A |